Global Bio Pharma Buffer Market Insights, Forecast to 2026

Publisher Name :
Date: 21-Apr-2020
No. of pages: 119
Inquire Before Buying

Bio Pharma Buffer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bio Pharma Buffer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Bio Pharma Buffer market is segmented into

- Phosphates Type

- Acetates Type

- TRIS Type

- Others

Segment by Application, the Bio Pharma Buffer market is segmented into

- Research Institution

- Pharmaceutical Industry

- Others

Regional and Country-level Analysis

The Bio Pharma Buffer market is analysed and market size information is provided by regions (countries).

The key regions covered in the Bio Pharma Buffer market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Bio Pharma Buffer Market Share Analysis

Bio Pharma Buffer market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bio Pharma Buffer business, the date to enter into the Bio Pharma Buffer market, Bio Pharma Buffer product introduction, recent developments, etc.

The major vendors covered:

- Avantor

- Alfa Aesar (Thermo Fisher)

- Merck

- Lonza

- Bio-Rad

- BD

- GE Healthcare

- Promega Corporation

- Hamilton Company

- XZL BIO-TECHNOLOGY

- SRL

Global Bio Pharma Buffer Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Market Segments
1.3 Key Bio Pharma Buffer Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bio Pharma Buffer Market Size Growth Rate by Type
1.4.2 Phosphates Type
1.4.3 Acetates Type
1.4.4 TRIS Type
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bio Pharma Buffer Market Size Growth Rate by Application
1.5.2 Research Institution
1.5.3 Pharmaceutical Industry
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Bio Pharma Buffer Industry Impact
1.6.1 How the Covid-19 is Affecting the Bio Pharma Buffer Industry
1.6.1.1 Bio Pharma Buffer Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Bio Pharma Buffer Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Bio Pharma Buffer Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Bio Pharma Buffer Market Size Estimates and Forecasts
2.1.1 Global Bio Pharma Buffer Revenue 2015-2026
2.1.2 Global Bio Pharma Buffer Sales 2015-2026
2.2 Bio Pharma Buffer Market Size by Region: 2020 Versus 2026
2.2.1 Global Bio Pharma Buffer Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bio Pharma Buffer Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bio Pharma Buffer Competitor Landscape by Players
3.1 Bio Pharma Buffer Sales by Manufacturers
3.1.1 Bio Pharma Buffer Sales by Manufacturers (2015-2020)
3.1.2 Bio Pharma Buffer Sales Market Share by Manufacturers (2015-2020)
3.2 Bio Pharma Buffer Revenue by Manufacturers
3.2.1 Bio Pharma Buffer Revenue by Manufacturers (2015-2020)
3.2.2 Bio Pharma Buffer Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bio Pharma Buffer Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bio Pharma Buffer Revenue in 2019
3.2.5 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bio Pharma Buffer Price by Manufacturers
3.4 Bio Pharma Buffer Manufacturing Base Distribution, Product Types
3.4.1 Bio Pharma Buffer Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bio Pharma Buffer Product Type
3.4.3 Date of International Manufacturers Enter into Bio Pharma Buffer Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Bio Pharma Buffer Market Size by Type (2015-2020)
4.1.1 Global Bio Pharma Buffer Sales by Type (2015-2020)
4.1.2 Global Bio Pharma Buffer Revenue by Type (2015-2020)
4.1.3 Bio Pharma Buffer Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bio Pharma Buffer Market Size Forecast by Type (2021-2026)
4.2.1 Global Bio Pharma Buffer Sales Forecast by Type (2021-2026)
4.2.2 Global Bio Pharma Buffer Revenue Forecast by Type (2021-2026)
4.2.3 Bio Pharma Buffer Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bio Pharma Buffer Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Bio Pharma Buffer Market Size by Application (2015-2020)
5.1.1 Global Bio Pharma Buffer Sales by Application (2015-2020)
5.1.2 Global Bio Pharma Buffer Revenue by Application (2015-2020)
5.1.3 Bio Pharma Buffer Price by Application (2015-2020)
5.2 Bio Pharma Buffer Market Size Forecast by Application (2021-2026)
5.2.1 Global Bio Pharma Buffer Sales Forecast by Application (2021-2026)
5.2.2 Global Bio Pharma Buffer Revenue Forecast by Application (2021-2026)
5.2.3 Global Bio Pharma Buffer Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bio Pharma Buffer by Country
6.1.1 North America Bio Pharma Buffer Sales by Country
6.1.2 North America Bio Pharma Buffer Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bio Pharma Buffer Market Facts & Figures by Type
6.3 North America Bio Pharma Buffer Market Facts & Figures by Application
7 Europe
7.1 Europe Bio Pharma Buffer by Country
7.1.1 Europe Bio Pharma Buffer Sales by Country
7.1.2 Europe Bio Pharma Buffer Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bio Pharma Buffer Market Facts & Figures by Type
7.3 Europe Bio Pharma Buffer Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bio Pharma Buffer by Region
8.1.1 Asia Pacific Bio Pharma Buffer Sales by Region
8.1.2 Asia Pacific Bio Pharma Buffer Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Type
8.3 Asia Pacific Bio Pharma Buffer Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bio Pharma Buffer by Country
9.1.1 Latin America Bio Pharma Buffer Sales by Country
9.1.2 Latin America Bio Pharma Buffer Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bio Pharma Buffer Market Facts & Figures by Type
9.3 Central & South America Bio Pharma Buffer Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bio Pharma Buffer by Country
10.1.1 Middle East and Africa Bio Pharma Buffer Sales by Country
10.1.2 Middle East and Africa Bio Pharma Buffer Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Type
10.3 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Application
11 Company Profiles
11.1 Avantor
11.1.1 Avantor Corporation Information
11.1.2 Avantor Description, Business Overview and Total Revenue
11.1.3 Avantor Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avantor Bio Pharma Buffer Products Offered
11.1.5 Avantor Recent Development
11.2 Alfa Aesar (Thermo Fisher)
11.2.1 Alfa Aesar (Thermo Fisher) Corporation Information
11.2.2 Alfa Aesar (Thermo Fisher) Description, Business Overview and Total Revenue
11.2.3 Alfa Aesar (Thermo Fisher) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
11.2.5 Alfa Aesar (Thermo Fisher) Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Bio Pharma Buffer Products Offered
11.3.5 Merck Recent Development
11.4 Lonza
11.4.1 Lonza Corporation Information
11.4.2 Lonza Description, Business Overview and Total Revenue
11.4.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lonza Bio Pharma Buffer Products Offered
11.4.5 Lonza Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Corporation Information
11.5.2 Bio-Rad Description, Business Overview and Total Revenue
11.5.3 Bio-Rad Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bio-Rad Bio Pharma Buffer Products Offered
11.5.5 Bio-Rad Recent Development
11.6 BD
11.6.1 BD Corporation Information
11.6.2 BD Description, Business Overview and Total Revenue
11.6.3 BD Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BD Bio Pharma Buffer Products Offered
11.6.5 BD Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Corporation Information
11.7.2 GE Healthcare Description, Business Overview and Total Revenue
11.7.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GE Healthcare Bio Pharma Buffer Products Offered
11.7.5 GE Healthcare Recent Development
11.8 Promega Corporation
11.8.1 Promega Corporation Corporation Information
11.8.2 Promega Corporation Description, Business Overview and Total Revenue
11.8.3 Promega Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Promega Corporation Bio Pharma Buffer Products Offered
11.8.5 Promega Corporation Recent Development
11.9 Hamilton Company
11.9.1 Hamilton Company Corporation Information
11.9.2 Hamilton Company Description, Business Overview and Total Revenue
11.9.3 Hamilton Company Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hamilton Company Bio Pharma Buffer Products Offered
11.9.5 Hamilton Company Recent Development
11.10 XZL BIO-TECHNOLOGY
11.10.1 XZL BIO-TECHNOLOGY Corporation Information
11.10.2 XZL BIO-TECHNOLOGY Description, Business Overview and Total Revenue
11.10.3 XZL BIO-TECHNOLOGY Sales, Revenue and Gross Margin (2015-2020)
11.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
11.10.5 XZL BIO-TECHNOLOGY Recent Development
11.1 Avantor
11.1.1 Avantor Corporation Information
11.1.2 Avantor Description, Business Overview and Total Revenue
11.1.3 Avantor Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avantor Bio Pharma Buffer Products Offered
11.1.5 Avantor Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bio Pharma Buffer Market Estimates and Projections by Region
12.1.1 Global Bio Pharma Buffer Sales Forecast by Regions 2021-2026
12.1.2 Global Bio Pharma Buffer Revenue Forecast by Regions 2021-2026
12.2 North America Bio Pharma Buffer Market Size Forecast (2021-2026)
12.2.1 North America: Bio Pharma Buffer Sales Forecast (2021-2026)
12.2.2 North America: Bio Pharma Buffer Revenue Forecast (2021-2026)
12.2.3 North America: Bio Pharma Buffer Market Size Forecast by Country (2021-2026)
12.3 Europe Bio Pharma Buffer Market Size Forecast (2021-2026)
12.3.1 Europe: Bio Pharma Buffer Sales Forecast (2021-2026)
12.3.2 Europe: Bio Pharma Buffer Revenue Forecast (2021-2026)
12.3.3 Europe: Bio Pharma Buffer Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bio Pharma Buffer Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bio Pharma Buffer Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bio Pharma Buffer Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bio Pharma Buffer Market Size Forecast by Region (2021-2026)
12.5 Latin America Bio Pharma Buffer Market Size Forecast (2021-2026)
12.5.1 Latin America: Bio Pharma Buffer Sales Forecast (2021-2026)
12.5.2 Latin America: Bio Pharma Buffer Revenue Forecast (2021-2026)
12.5.3 Latin America: Bio Pharma Buffer Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bio Pharma Buffer Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bio Pharma Buffer Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bio Pharma Buffer Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bio Pharma Buffer Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Bio Pharma Buffer Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bio Pharma Buffer Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Bio Pharma Buffer Market Segments
Table 2. Ranking of Global Top Bio Pharma Buffer Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bio Pharma Buffer Market Size Growth Rate by Type 2020-2026 (kL) & (US$ Million)
Table 4. Major Manufacturers of Phosphates Type
Table 5. Major Manufacturers of Acetates Type
Table 6. Major Manufacturers of TRIS Type
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Bio Pharma Buffer Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Bio Pharma Buffer Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Bio Pharma Buffer Players to Combat Covid-19 Impact
Table 13. Global Bio Pharma Buffer Market Size Growth Rate by Application 2020-2026 (kL)
Table 14. Global Bio Pharma Buffer Market Size by Region (kL) & (US$ Million): 2020 VS 2026
Table 15. Global Bio Pharma Buffer Sales by Regions 2015-2020 (kL)
Table 16. Global Bio Pharma Buffer Sales Market Share by Regions (2015-2020)
Table 17. Global Bio Pharma Buffer Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Bio Pharma Buffer Sales by Manufacturers (2015-2020) (kL)
Table 19. Global Bio Pharma Buffer Sales Share by Manufacturers (2015-2020)
Table 20. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio Pharma Buffer as of 2019)
Table 22. Bio Pharma Buffer Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Bio Pharma Buffer Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Bio Pharma Buffer Price (2015-2020) (USD/L)
Table 25. Bio Pharma Buffer Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Bio Pharma Buffer Product Type
Table 27. Date of International Manufacturers Enter into Bio Pharma Buffer Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 30. Global Bio Pharma Buffer Sales Share by Type (2015-2020)
Table 31. Global Bio Pharma Buffer Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Bio Pharma Buffer Revenue Share by Type (2015-2020)
Table 33. Bio Pharma Buffer Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 34. Global Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 35. Global Bio Pharma Buffer Sales Share by Application (2015-2020)
Table 36. North America Bio Pharma Buffer Sales by Country (2015-2020) (kL)
Table 37. North America Bio Pharma Buffer Sales Market Share by Country (2015-2020)
Table 38. North America Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Bio Pharma Buffer Revenue Market Share by Country (2015-2020)
Table 40. North America Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 41. North America Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 42. North America Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 43. North America Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 44. Europe Bio Pharma Buffer Sales by Country (2015-2020) (kL)
Table 45. Europe Bio Pharma Buffer Sales Market Share by Country (2015-2020)
Table 46. Europe Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Bio Pharma Buffer Revenue Market Share by Country (2015-2020)
Table 48. Europe Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 49. Europe Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 50. Europe Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 51. Europe Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Bio Pharma Buffer Sales by Region (2015-2020) (kL)
Table 53. Asia Pacific Bio Pharma Buffer Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Bio Pharma Buffer Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 57. Asia Pacific Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 59. Asia Pacific Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 60. Latin America Bio Pharma Buffer Sales by Country (2015-2020) (kL)
Table 61. Latin America Bio Pharma Buffer Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Bio Pharma Buffer Revenue Market Share by Country (2015-2020)
Table 64. Latin America Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 65. Latin America Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 66. Latin America Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 67. Latin America Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Bio Pharma Buffer Sales by Country (2015-2020) (kL)
Table 69. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Bio Pharma Buffer Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Bio Pharma Buffer Sales by Type (2015-2020) (kL)
Table 73. Middle East and Africa Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Bio Pharma Buffer Sales by Application (2015-2020) (kL)
Table 75. Middle East and Africa Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Table 76. Avantor Corporation Information
Table 77. Avantor Description and Major Businesses
Table 78. Avantor Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 79. Avantor Product
Table 80. Avantor Recent Development
Table 81. Alfa Aesar (Thermo Fisher) Corporation Information
Table 82. Alfa Aesar (Thermo Fisher) Description and Major Businesses
Table 83. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 84. Alfa Aesar (Thermo Fisher) Product
Table 85. Alfa Aesar (Thermo Fisher) Recent Development
Table 86. Merck Corporation Information
Table 87. Merck Description and Major Businesses
Table 88. Merck Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 89. Merck Product
Table 90. Merck Recent Development
Table 91. Lonza Corporation Information
Table 92. Lonza Description and Major Businesses
Table 93. Lonza Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 94. Lonza Product
Table 95. Lonza Recent Development
Table 96. Bio-Rad Corporation Information
Table 97. Bio-Rad Description and Major Businesses
Table 98. Bio-Rad Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 99. Bio-Rad Product
Table 100. Bio-Rad Recent Development
Table 101. BD Corporation Information
Table 102. BD Description and Major Businesses
Table 103. BD Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 104. BD Product
Table 105. BD Recent Development
Table 106. GE Healthcare Corporation Information
Table 107. GE Healthcare Description and Major Businesses
Table 108. GE Healthcare Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 109. GE Healthcare Product
Table 110. GE Healthcare Recent Development
Table 111. Promega Corporation Corporation Information
Table 112. Promega Corporation Description and Major Businesses
Table 113. Promega Corporation Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 114. Promega Corporation Product
Table 115. Promega Corporation Recent Development
Table 116. Hamilton Company Corporation Information
Table 117. Hamilton Company Description and Major Businesses
Table 118. Hamilton Company Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 119. Hamilton Company Product
Table 120. Hamilton Company Recent Development
Table 121. XZL BIO-TECHNOLOGY Corporation Information
Table 122. XZL BIO-TECHNOLOGY Description and Major Businesses
Table 123. XZL BIO-TECHNOLOGY Bio Pharma Buffer Production (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 124. XZL BIO-TECHNOLOGY Product
Table 125. XZL BIO-TECHNOLOGY Recent Development
Table 126. SRL Corporation Information
Table 127. SRL Description and Major Businesses
Table 128. SRL Bio Pharma Buffer Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 129. SRL Product
Table 130. SRL Recent Development
Table 131. Global Bio Pharma Buffer Sales Forecast by Regions (2021-2026) (kL)
Table 132. Global Bio Pharma Buffer Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Bio Pharma Buffer Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Bio Pharma Buffer Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Bio Pharma Buffer Sales Forecast by Country (2021-2026) (kL)
Table 136. North America: Bio Pharma Buffer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Bio Pharma Buffer Sales Forecast by Country (2021-2026) (kL)
Table 138. Europe: Bio Pharma Buffer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Bio Pharma Buffer Sales Forecast by Region (2021-2026) (kL)
Table 140. Asia Pacific: Bio Pharma Buffer Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Bio Pharma Buffer Sales Forecast by Country (2021-2026) (kL)
Table 142. Latin America: Bio Pharma Buffer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Bio Pharma Buffer Sales Forecast by Country (2021-2026) (kL)
Table 144. Middle East and Africa: Bio Pharma Buffer Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Bio Pharma Buffer Players
Table 149. Bio Pharma Buffer Customers List
Table 150. Bio Pharma Buffer Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio Pharma Buffer Product Picture
Figure 2. Global Bio Pharma Buffer Sales Market Share by Type in 2020 & 2026
Figure 3. Phosphates Type Product Picture
Figure 4. Acetates Type Product Picture
Figure 5. TRIS Type Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bio Pharma Buffer Sales Market Share by Application in 2020 & 2026
Figure 8. Research Institution
Figure 9. Pharmaceutical Industry
Figure 10. Others
Figure 11. Bio Pharma Buffer Report Years Considered
Figure 12. Global Bio Pharma Buffer Market Size 2015-2026 (US$ Million)
Figure 13. Global Bio Pharma Buffer Sales 2015-2026 (kL)
Figure 14. Global Bio Pharma Buffer Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Bio Pharma Buffer Sales Market Share by Region (2015-2020)
Figure 16. Global Bio Pharma Buffer Sales Market Share by Region in 2019
Figure 17. Global Bio Pharma Buffer Revenue Market Share by Region (2015-2020)
Figure 18. Global Bio Pharma Buffer Revenue Market Share by Region in 2019
Figure 19. Global Bio Pharma Buffer Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Bio Pharma Buffer Revenue in 2019
Figure 21. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Bio Pharma Buffer Sales Market Share by Type (2015-2020)
Figure 23. Global Bio Pharma Buffer Sales Market Share by Type in 2019
Figure 24. Global Bio Pharma Buffer Revenue Market Share by Type (2015-2020)
Figure 25. Global Bio Pharma Buffer Revenue Market Share by Type in 2019
Figure 26. Global Bio Pharma Buffer Market Share by Price Range (2015-2020)
Figure 27. Global Bio Pharma Buffer Sales Market Share by Application (2015-2020)
Figure 28. Global Bio Pharma Buffer Sales Market Share by Application in 2019
Figure 29. Global Bio Pharma Buffer Revenue Market Share by Application (2015-2020)
Figure 30. Global Bio Pharma Buffer Revenue Market Share by Application in 2019
Figure 31. North America Bio Pharma Buffer Sales Growth Rate 2015-2020 (kL)
Figure 32. North America Bio Pharma Buffer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Bio Pharma Buffer Sales Market Share by Country in 2019
Figure 34. North America Bio Pharma Buffer Revenue Market Share by Country in 2019
Figure 35. U.S. Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 36. U.S. Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 38. Canada Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Bio Pharma Buffer Market Share by Type in 2019
Figure 40. North America Bio Pharma Buffer Market Share by Application in 2019
Figure 41. Europe Bio Pharma Buffer Sales Growth Rate 2015-2020 (kL)
Figure 42. Europe Bio Pharma Buffer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Bio Pharma Buffer Sales Market Share by Country in 2019
Figure 44. Europe Bio Pharma Buffer Revenue Market Share by Country in 2019
Figure 45. Germany Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 46. Germany Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 48. France Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 50. U.K. Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 52. Italy Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 54. Russia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Bio Pharma Buffer Market Share by Type in 2019
Figure 56. Europe Bio Pharma Buffer Market Share by Application in 2019
Figure 57. Asia Pacific Bio Pharma Buffer Sales Growth Rate 2015-2020 (kL)
Figure 58. Asia Pacific Bio Pharma Buffer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Bio Pharma Buffer Sales Market Share by Region in 2019
Figure 60. Asia Pacific Bio Pharma Buffer Revenue Market Share by Region in 2019
Figure 61. China Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 62. China Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 64. Japan Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 66. South Korea Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 68. India Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 70. Australia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 72. Taiwan Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 74. Indonesia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 76. Thailand Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 78. Malaysia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 80. Philippines Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 82. Vietnam Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Bio Pharma Buffer Market Share by Type in 2019
Figure 84. Asia Pacific Bio Pharma Buffer Market Share by Application in 2019
Figure 85. Latin America Bio Pharma Buffer Sales Growth Rate 2015-2020 (kL)
Figure 86. Latin America Bio Pharma Buffer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Bio Pharma Buffer Sales Market Share by Country in 2019
Figure 88. Latin America Bio Pharma Buffer Revenue Market Share by Country in 2019
Figure 89. Mexico Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 90. Mexico Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 92. Brazil Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 94. Argentina Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Bio Pharma Buffer Market Share by Type in 2019
Figure 96. Latin America Bio Pharma Buffer Market Share by Application in 2019
Figure 97. Middle East and Africa Bio Pharma Buffer Sales Growth Rate 2015-2020 (kL)
Figure 98. Middle East and Africa Bio Pharma Buffer Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country in 2019
Figure 101. Turkey Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 102. Turkey Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 104. Saudi Arabia Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Bio Pharma Buffer Sales Growth Rate (2015-2020) (kL)
Figure 106. UAE Bio Pharma Buffer Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Bio Pharma Buffer Market Share by Type in 2019
Figure 108. Middle East and Africa Bio Pharma Buffer Market Share by Application in 2019
Figure 109. Avantor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Alfa Aesar (Thermo Fisher) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Promega Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Hamilton Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. XZL BIO-TECHNOLOGY Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. SRL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Bio Pharma Buffer Sales Growth Rate Forecast (2021-2026) (kL)
Figure 121. North America Bio Pharma Buffer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Bio Pharma Buffer Sales Growth Rate Forecast (2021-2026) (kL)
Figure 123. Europe Bio Pharma Buffer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Bio Pharma Buffer Sales Growth Rate Forecast (2021-2026) (kL)
Figure 125. Asia Pacific Bio Pharma Buffer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Bio Pharma Buffer Sales Growth Rate Forecast (2021-2026) (kL)
Figure 127. Latin America Bio Pharma Buffer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Bio Pharma Buffer Sales Growth Rate Forecast (2021-2026) (kL)
Figure 129. Middle East and Africa Bio Pharma Buffer Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs